共 50 条
- [21] Discovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approachFUTURE MEDICINAL CHEMISTRY, 2017, 9 (01) : 7 - 24Chen, Shangying论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeQin, Chu论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeSin, Jia En论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeYang, Xuan论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeTao, Lin论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeZeng, Xian论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeZhang, Peng论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeGao, Chun Mei论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Kivita Innovat Drug Discovery Inst, Shenzhen, Guangdong, Peoples R China Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen, Guangdong, Peoples R China Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeJiang, Yu Yang论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Kivita Innovat Drug Discovery Inst, Shenzhen, Guangdong, Peoples R China Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen, Guangdong, Peoples R China Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeZhang, Cheng论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55902 USA Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeChen, Yu Zong论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, SingaporeChui, Wai Keung论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore Natl Univ Singapore, Dept Pharm, 18 Sci Dr 4, Singapore 117543, Singapore
- [22] Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsBRITISH JOURNAL OF CANCER, 2004, 91 (07) : 1391 - 1398Dev, IK论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USADornsife, RE论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAHopper, TM论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAOnori, JA论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAMiller, CG论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAHarrington, LE论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USADold, KM论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAMullin, RJ论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAJohnson, JH论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USACrosby, RM论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USATruesdale, AT论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAEpperly, AH论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAHinkle, KW论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USACheung, M论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAStafford, JA论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USALuttrell, DK论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USAKumar, R论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Res Triangle Pk, NC 27709 USA GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
- [23] Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour modelsBritish Journal of Cancer, 2004, 91 : 1391 - 1398I K Dev论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,R E Dornsife论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,T M Hopper论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,J A Onori论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,C G Miller论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,L E Harrington论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,K M Dold论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,R J Mullin论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,J H Johnson论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,R M Crosby论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,A T Truesdale论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,A H Epperly论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,K W Hinkle论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,M Cheung论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,J A Stafford论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,D K Luttrell论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,R Kumar论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline,
- [24] Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking StudiesMOLECULES, 2021, 26 (10):Altamimi, Abdulmalik S.论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaEl-Azab, Adel S.论文数: 0 引用数: 0 h-index: 0机构: King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaAbdelhamid, Sami G.论文数: 0 引用数: 0 h-index: 0机构: Al Azhar Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11884, Egypt Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaAlamri, Mubarak A.论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaBayoumi, Ashraf H.论文数: 0 引用数: 0 h-index: 0机构: Al Azhar Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Cairo 11884, Egypt Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaAlqahtani, Safar M.论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaAlabbas, Alhumaidi B.论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaAltharawi, Ali, I论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaAlossaimi, Manal A.论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi ArabiaMohamed, Menshawy A.论文数: 0 引用数: 0 h-index: 0机构: Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia Al Azhar Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Cairo 11884, Egypt Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj 11942, Saudi Arabia
- [25] Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1464 - 1470Ghorab, Mostafa M.论文数: 0 引用数: 0 h-index: 0机构: EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, Egypt EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, EgyptRagab, Fatma A.论文数: 0 引用数: 0 h-index: 0机构: Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, EgyptHeiba, Helmy, I论文数: 0 引用数: 0 h-index: 0机构: EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, Egypt EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, EgyptEl-Gazzar, Marwa G.论文数: 0 引用数: 0 h-index: 0机构: EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, Egypt EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, EgyptEl-Gazzar, Mostafa G. M.论文数: 0 引用数: 0 h-index: 0机构: EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, Egypt EAEA, NCRRT, Dept Drug Radiat Res, POB 29, Cairo, Egypt
- [26] Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6231 - 6235Farmer, Luc J.论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USABemis, Guy论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USABritt, Shawn D.论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USACochran, John论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USAConnors, Martin论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USAHarrington, Edmund M.论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USAHoock, Thomas论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USAMarkland, William论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USANanthakumar, Suganthini论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USATaslimi, Paul论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USATer Haar, Ernst论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USAWang, Jian论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USAZhaveri, Darshana论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USASalituro, Francesco G.论文数: 0 引用数: 0 h-index: 0机构: Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA
- [27] Structure activity relationships of chrysoeriol and analogs as dual c-Met and VEGFR2 tyrosine kinase inhibitorsONCOLOGY REPORTS, 2018, 40 (03) : 1650 - 1656Lai, Shuang论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaChen, Jun-Ning论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaHuang, Han-Wei论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Affiliated Hosp 1, Dept Surg Oncol & Gen Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaZhang, Xiang-Yu论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaJiang, Hai-Lun论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaLi, Wei论文数: 0 引用数: 0 h-index: 0机构: Shenyang Univ Chem Technol, Dept Pharmaceut Engn, Shenyang 110042, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaWang, Peng-Liang论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Affiliated Hosp 1, Dept Surg Oncol & Gen Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaWang, Jian论文数: 0 引用数: 0 h-index: 0机构: Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R ChinaLiu, Fu-Nan论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Affiliated Hosp 1, Dept Surg Oncol & Gen Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
- [28] Synthesis, SAR and in vivo activity of CEP 5214, a novel and potent VEGFR2 kinase inhibitor.ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U22 - U22Gingrich, DE论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USAAlbom, MS论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USAYang, SX论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USAAngeles, TS论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USARobinson, CS论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USAHunter, K论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USAChang, H论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USARuggeri, BA论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USAHudkins, RL论文数: 0 引用数: 0 h-index: 0机构: Cephalon Inc, Dept Med Chem, W Chester, PA 19380 USA
- [29] Impact of aryloxy-linked quinazolines: A novel series of selective VEGFR-2 receptor tyrosine kinase inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 2106 - 2112Garofalo, Antonio论文数: 0 引用数: 0 h-index: 0机构: UDSL, ICPAL, EA 4481, F-59006 Lille, France Univ Lille Nord France, F-59000 Lille, France UDSL, ICPAL, EA 4481, F-59006 Lille, France论文数: 引用数: h-index:机构:Six, Perrine论文数: 0 引用数: 0 h-index: 0机构: UDSL, ICPAL, EA 4481, F-59006 Lille, France Univ Lille Nord France, F-59000 Lille, France UDSL, ICPAL, EA 4481, F-59006 Lille, FranceLemoine, Amelie论文数: 0 引用数: 0 h-index: 0机构: UDSL, ICPAL, EA 4481, F-59006 Lille, France Univ Lille Nord France, F-59000 Lille, France UDSL, ICPAL, EA 4481, F-59006 Lille, FranceRavez, Severine论文数: 0 引用数: 0 h-index: 0机构: UDSL, ICPAL, EA 4481, F-59006 Lille, France Univ Lille Nord France, F-59000 Lille, France UDSL, ICPAL, EA 4481, F-59006 Lille, France论文数: 引用数: h-index:机构:Depreux, Patrick论文数: 0 引用数: 0 h-index: 0机构: UDSL, ICPAL, EA 4481, F-59006 Lille, France Univ Lille Nord France, F-59000 Lille, France UDSL, ICPAL, EA 4481, F-59006 Lille, France
- [30] Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ InhibitorsJOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5467 - 5482Leahy, James W.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USABuhr, Chris A.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAJohnson, Henry W. B.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAKim, Byung Gyu论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USABaik, TaeGon论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USACannoy, Jonah论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAForsyth, Timothy P.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAJeong, Joon Won论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USALee, Matthew S.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAMa, Sunghoon论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USANoson, Kevin论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAWang, Longcheng论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAWilliams, Matthew论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USANuss, John M.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USABrooks, Eric论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAFoster, Paul论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAGoon, Leanne论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAHeald, Nathan论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAHolst, Charles论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAJaeger, Christopher论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USALam, Scott论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USALougheed, Julie论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USALam Nguyen论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAPlonowski, Arthur论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USASong, Joanne论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAStout, Thomas论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAWu, Xiang论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAYakes, Michael F.论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAYu, Peiwen论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USAZhang, Wentao论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USALamb, Peter论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USARaeber, Olivia论文数: 0 引用数: 0 h-index: 0机构: Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA Exelixis, Dept Drug Discovery, San Francisco, CA 94083 USA